Healthcare provider profile · identity verified

Stephen Michael Miller, DO

Family Practice · PETERSTOWN, WV · NPI 1871519660

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	328	96
Rosuvastatin Calcium	Rosuvastatin Calcium	281	95
Gabapentin	Gabapentin	218	41
Famotidine	Famotidine	217	69
Omeprazole	Omeprazole	210	62
Furosemide	Furosemide	208	71
Amlodipine Besylate	Amlodipine Besylate	207	67
Potassium Chloride	Potassium Chloride	158	59
Pantoprazole Sodium	Pantoprazole Sodium	139	49
Alprazolam	Alprazolam	137	17
Lisinopril	Lisinopril	131	44
Lorazepam	Lorazepam	131	39
Albuterol Sulfate Hfa	Albuterol Sulfate	129	55
Losartan Potassium	Losartan Potassium	120	46
Trazodone Hcl	Trazodone Hcl	120	37
Atorvastatin Calcium	Atorvastatin Calcium	113	37
Meloxicam	Meloxicam	112	38
Tamsulosin Hcl	Tamsulosin Hcl	105	27
Metformin Hcl	Metformin Hcl	101	36
Cefdinir	Cefdinir	98	79
Hydrochlorothiazide	Hydrochlorothiazide	96	34
Pravastatin Sodium	Pravastatin Sodium	95	36
Clonazepam	Clonazepam	94	17
Metoprolol Succinate	Metoprolol Succinate	88	30
Montelukast Sodium	Montelukast Sodium	86	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	85	25
Metoprolol Tartrate	Metoprolol Tartrate	85	34
Mounjaro	Tirzepatide	82	17
Fluoxetine Hcl	Fluoxetine Hcl	78	24
Escitalopram Oxalate	Escitalopram Oxalate	76	30
Clopidogrel	Clopidogrel Bisulfate	73	23
Donepezil Hcl	Donepezil Hcl	73	16
Eliquis	Apixaban	73	21
Doxazosin Mesylate	Doxazosin Mesylate	71	18
Ibuprofen	Ibuprofen	71	23
Nifedipine Er	Nifedipine	71	23
Nebivolol Hcl	Nebivolol Hcl	63	17
Simvastatin	Simvastatin	61	16
Allopurinol	Allopurinol	59	18
Buspirone Hcl	Buspirone Hcl	58	21
Carvedilol	Carvedilol	58	18
Glimepiride	Glimepiride	58	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	18
Mirtazapine	Mirtazapine	58	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	58	19
Doxycycline Hyclate	Doxycycline Hyclate	57	45
Prednisone	Prednisone	57	25
Ondansetron Hcl	Ondansetron Hcl	55	31
Citalopram Hbr	Citalopram Hydrobromide	54	14
Duloxetine Hcl	Duloxetine Hcl	53	18
Venlafaxine Hcl Er	Venlafaxine Hcl	53	13
Ezetimibe	Ezetimibe	51	16
Methylprednisolone	Methylprednisolone	49	35
Azelastine Hcl	Azelastine Hcl	48	20
Levofloxacin	Levofloxacin	47	43
Ropinirole Hcl	Ropinirole Hcl	46	12
Irbesartan	Irbesartan	44	13
Pregabalin	Pregabalin	44	suppressed
Celecoxib	Celecoxib	43	17
Ozempic	Semaglutide	43	suppressed
Sertraline Hcl	Sertraline Hcl	43	18
Finasteride	Finasteride	42	12
Glipizide Er	Glipizide	42	13
Nadolol	Nadolol	41	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	40	31
Hydroxyzine Hcl	Hydroxyzine Hcl	40	13
Paroxetine Hcl	Paroxetine Hcl	40	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	13
Hydralazine Hcl	Hydralazine Hcl	38	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	37	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	37	14
Vitamin D2	Ergocalciferol (Vitamin D2)	37	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Nystatin	Nystatin	34	17
Topiramate	Topiramate	34	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Alendronate Sodium	Alendronate Sodium	32	suppressed
Azithromycin	Azithromycin	32	30
Fluticasone Propionate	Fluticasone Propionate	31	15
Enalapril Maleate	Enalapril Maleate	30	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	30	13
Fenofibrate	Fenofibrate,micronized	30	suppressed
Clonidine Hcl	Clonidine Hcl	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	13
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	29	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Atenolol	Atenolol	28	suppressed
Fluconazole	Fluconazole	28	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	28	19
Metolazone	Metolazone	28	suppressed
Clindamycin Hcl	Clindamycin Hcl	27	21
Amoxicillin	Amoxicillin	26	23
Np Thyroid	Thyroid,pork	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	25	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	14
Telmisartan	Telmisartan	25	suppressed
Premarin	Estrogens, Conjugated	24	suppressed
Risedronate Sodium	Risedronate Sodium	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	20
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	11
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	21	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	17
Shingrix	Varicella-Zoster Ge/As01b/Pf	19	14
Alfuzosin Hcl Er	Alfuzosin Hcl	18	suppressed
Diazepam	Diazepam	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Indomethacin	Indomethacin	18	suppressed
Torsemide	Torsemide	18	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	16	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	16	11
Methocarbamol	Methocarbamol	16	13
Cephalexin	Cephalexin	15	14
Myrbetriq	Mirabegron	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Megestrol Acetate	Megestrol Acetate	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	13	suppressed
Glipizide	Glipizide	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Hydroxyurea	Hydroxyurea	12	suppressed
Ibu	Ibuprofen	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Risperidone	Risperidone	12	suppressed
Baclofen	Baclofen	11	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	11	11
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error